Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1923 1
1936 1
1945 1
1946 3
1947 4
1948 7
1949 1
1950 2
1951 1
1952 5
1953 6
1954 12
1955 9
1956 4
1957 12
1958 10
1959 10
1960 10
1961 12
1962 16
1963 17
1964 14
1965 21
1966 15
1967 10
1968 21
1969 16
1970 18
1971 8
1972 10
1973 15
1974 14
1975 24
1976 28
1977 16
1978 23
1979 17
1980 28
1981 24
1982 27
1983 30
1984 46
1985 44
1986 33
1987 35
1988 40
1989 42
1990 50
1991 38
1992 45
1993 34
1994 41
1995 42
1996 40
1997 51
1998 50
1999 49
2000 64
2001 58
2002 53
2003 55
2004 60
2005 56
2006 66
2007 73
2008 95
2009 82
2010 72
2011 87
2012 82
2013 95
2014 121
2015 111
2016 118
2017 133
2018 130
2019 125
2020 150
2021 186
2022 205
2023 180
2024 183
2025 190
2026 123

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,812 results

Results by year

Filters applied: . Clear all
Page 1
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: cohen a. N Engl J Med. 2023 Jan 26;388(4):319-332. doi: 10.1056/NEJMoa2211582. Epub 2022 Dec 13. N Engl J Med. 2023. PMID: 36511784 Clinical Trial.
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: cohen a. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Free PMC article. Clinical Trial.
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.
Brown JR, Eichhorst B, Lamanna N, O'Brien SM, Tam CS, Qiu L, Jurczak W, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Wang M, Salmi T, Wang L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: cohen a. Blood. 2024 Dec 26;144(26):2706-2717. doi: 10.1182/blood.2024024667. Blood. 2024. PMID: 39316666 Free PMC article. Clinical Trial.
In reply.
Cohen A, Rolston D. Cohen A, et al. Ann Emerg Med. 2024 Nov;84(5):602-603. doi: 10.1016/j.annemergmed.2024.06.020. Ann Emerg Med. 2024. PMID: 39428204 No abstract available.
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.
Weiner I, Kahan-Hanum M, Buchstab N, Zelcbuch L, Navok S, Sherman I, Nicenboim J, Axelrod T, Berko-Ashur D, Olshina M, Mordoch R, Jablonska J, Gera-Inbar T, Vainberg-Slutskin I, Blumenfeld B, Sberro-Livnat H, Moses A, Nevenzel H, Levy-Saar I, Gold J, Goldberg M, Tchernorudsky N, Ben-Yishay N, Cohen T, Kario E, Levovich I, Safonov R, Tzur Y, Zarchin Y, Lev V, Elharar Y, Safyon-Gartman E, Gahali-Sass I, Puttagunta S, Ussery X, Vilchez R, Rappo U, Zak N, Golembo M, Cohen A, Koff J, Kerem E, Sorek R, Bassan M. Weiner I, et al. Among authors: cohen a. Nat Commun. 2025 Jul 1;16(1):5579. doi: 10.1038/s41467-025-60598-4. Nat Commun. 2025. PMID: 40593506 Free PMC article. Clinical Trial.
Endoscopic Ultrasound-Guided Biliary Drainage of First Intent With a Lumen-Apposing Metal Stent vs Endoscopic Retrograde Cholangiopancreatography in Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Study (ELEMENT Trial).
Chen YI, Sahai A, Donatelli G, Lam E, Forbes N, Mosko J, Paquin SC, Donnellan F, Chatterjee A, Telford J, Miller C, Desilets E, Sandha G, Kenshil S, Mohamed R, May G, Gan I, Barkun J, Calo N, Nawawi A, Friedman G, Cohen A, Maniere T, Chaudhury P, Metrakos P, Zogopoulos G, Bessissow A, Khalil JA, Baffis V, Waschke K, Parent J, Soulellis C, Khashab M, Kunda R, Geraci O, Martel M, Schwartzman K, Fiore JF Jr, Rahme E, Barkun A. Chen YI, et al. Among authors: cohen a. Gastroenterology. 2023 Nov;165(5):1249-1261.e5. doi: 10.1053/j.gastro.2023.07.024. Epub 2023 Aug 6. Gastroenterology. 2023. PMID: 37549753 Free article. Clinical Trial.
A new beginning in continuity.
Cohen A, Iung B; Editorial and Scientific Committees. Cohen A, et al. Arch Cardiovasc Dis. 2023 Aug-Sep;116(8-9):365. doi: 10.1016/j.acvd.2023.07.001. Epub 2023 Jul 17. Arch Cardiovasc Dis. 2023. PMID: 37635028 Free article. No abstract available.
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Shadman M, et al. Among authors: cohen a. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16. Lancet Haematol. 2023. PMID: 36400069 Clinical Trial.
3,812 results